Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
Priscila Badia AlonsoKiersten W RicciJuan P GurriaRoshni DasguptaManish PatelAdrienne M HammilllPublished in: Pediatric blood & cancer (2020)
Topical sirolimus appears to be a beneficial therapy for lymphatic blebbing associated with lymphatic malformations or mixed malformations with a lymphatic component, although benefit in other VA remains unclear. Topical sirolimus was well-tolerated with minimal side effects.